160 related articles for article (PubMed ID: 650082)
1. Clinical use of hemostatic agents.
Lowe GD; Lawson DH
J Maine Med Assoc; 1978 Mar; 69(3):87-97. PubMed ID: 650082
[No Abstract] [Full Text] [Related]
2. [Drug therapy of hemorrhagic syndromes. Part I].
Ballerini G
Clin Ter; 1974 Jul; 70(2):117-45. PubMed ID: 4409281
[No Abstract] [Full Text] [Related]
3. [Use of hemostatic preparations in obstetrical hemorrhages].
Pavlovskiĭ DP; Mikaĭlenko ET
Pediatr Akus Ginekol; 1976; (1):33-7. PubMed ID: 787905
[No Abstract] [Full Text] [Related]
4. [Blood coagulation therapy in liver cirrhosis].
Garcia-Conde Bru FJ; Rodrigo Gomez JM
Rev Esp Enferm Apar Dig; 1969 May; 28(5):695-702. PubMed ID: 5344674
[No Abstract] [Full Text] [Related]
5. [Therapy of plasma coagulation defects. II. Acquired coagulation disorders].
Schmutzler R
Dtsch Med Wochenschr; 1966 Feb; 91(7):316-8. PubMed ID: 5295337
[No Abstract] [Full Text] [Related]
6. [Hepatic failure and disorders of coagulation (author's transl)].
Ohler WG
Leber Magen Darm; 1977 Aug; 7(4):270-6. PubMed ID: 895329
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic alternatives to transfusion.
Ness PM
Vox Sang; 2002 Aug; 83 Suppl 1():3-6. PubMed ID: 12617091
[No Abstract] [Full Text] [Related]
8. [Experience with the increase of hemostatic action of blood transfusion in functional uterine hemorrhage].
ROZHINSKII MM
Akush Ginekol (Mosk); 1958; 34(4):93-4. PubMed ID: 13582759
[No Abstract] [Full Text] [Related]
9. [Vitamin K-controlled diet: problems and prospects].
Miggiano GA; Robilotta L
Clin Ter; 2005; 156(1-2):41-6. PubMed ID: 16080660
[TBL] [Abstract][Full Text] [Related]
10. [Therapy of disseminated intravascular coagulation].
Matsuda T
Rinsho Byori; 1985 Jun; Spec No 63():79-89. PubMed ID: 3930817
[No Abstract] [Full Text] [Related]
11. A comparison of antifibrinolytic agents used in hemostatic fibrin sealants.
Busuttil RW
J Am Coll Surg; 2003 Dec; 197(6):1021-8. PubMed ID: 14644291
[No Abstract] [Full Text] [Related]
12. Coagulation disturbance in profound hypothermia: the influence of anti-fibrinolytic therapy.
Westaby S
Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):246-56. PubMed ID: 9263343
[TBL] [Abstract][Full Text] [Related]
13. Management of bleeding in patients with advanced cancer.
Pereira J; Phan T
Oncologist; 2004; 9(5):561-70. PubMed ID: 15477642
[TBL] [Abstract][Full Text] [Related]
14. [Coagulation factors and hemostatic agents].
Deneys V; Hermans C
J Pharm Belg; 2004; 59(1):27-34. PubMed ID: 15129577
[TBL] [Abstract][Full Text] [Related]
15. [Recent aspects of the coagulation process, circumstances for its influencing by drugs].
Montigel C
Zentralbl Phlebol; 1968 Feb; 7(1):83-8. PubMed ID: 5682818
[No Abstract] [Full Text] [Related]
16. Hemostasis.
Breckenridge RT
Surg Annu; 1973; 5():145-55. PubMed ID: 4602213
[No Abstract] [Full Text] [Related]
17. Route of vitamin K administration for elevated INRs in the acute inpatient setting.
Mersfelder TL
Med Health R I; 2005 Dec; 88(12):441-2. PubMed ID: 16408720
[No Abstract] [Full Text] [Related]
18. [Antifibrinolytic agents and their therapeutic use].
Fischer M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):64-77. PubMed ID: 4189375
[No Abstract] [Full Text] [Related]
19. [Hemostatic effects of menaquinone-4 (K2) on various types of hemorrhagic diathesis in rats and comparison with other hemostatic agents].
Tajima TO; Ogo T; Miyao K
Nihon Yakurigaku Zasshi; 1971 Sep; 46(5):478-85. PubMed ID: 4110973
[No Abstract] [Full Text] [Related]
20. [Changes brought about in blood coagulation in the newborn by administration of vitamin K2. 3. Clinical application of vitamin K2 after exchange transfusion (author's transl)].
Suzuki S
Z Kinderheilkd; 1973 Oct; 115(3):261-6. PubMed ID: 4770089
[No Abstract] [Full Text] [Related]
[Next] [New Search]
